Dr. Mark Sherrid

Biography

Mark V. Sherrid, MD is a Professor and the Director of the Hypertrophic Cardiomyopathy Program at NYU Langone Health. He specializes in the treatment of hypertrophic cardiomyopathy, a condition where the heart muscle thickens, and has been involved in the diagnosis and management of this condition for over 20 years. Dr. Sherrid's expertise has led to significant advancements in treatment options, improving outcomes for his patients. He leads a team that has cared for over 2,500 individuals with this condition, developing tailored medical and surgical treatments. His background includes training at the California Pacific Medical Center and the completion of his residency at St Luke's Hospital Center in New York. Dr. Sherrid is passionate about educating patients on their conditions and works to ensure they have a thorough understanding of their diagnosis and treatment options. His contributions to the field include multiple publications, which have led to the adoption of new treatments within the cardiology community. Dr. Sherrid aims to address unresolved issues in the management of hypertrophic cardiomyopathy through ongoing research, particularly focusing on innovative therapies.

Research Interests

Experience